Use of mTOR inhibitor and chloroquine for treating cancer

Number of patents in Portfolio can not be more than 2000

United States of America

PATENT NO 11285143
APP PUB NO 20200009127A1
SERIAL NO

16490892

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed herein are uses of a mammalian target of rapamycin (mTOR) inhibitor and chloroquine or analogue thereof in the manufacture of a medicament for treating cancer patients who are not responsive to a hormone therapy and an immunotherapy. In particular, the medicament is used during the hormone therapy and the immunotherapy to sensitize the patients to the hormone therapy and the immunotherapy.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
JOHNPRO BIOTECH INC2F NO 118 HOUGANG ST SHILIN DIST TAIPEI CITY 111

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chi, Kwan-Hwa Taipei, TW 12 16
Chiang, Hsin-Chien Taipei, TW 13 14
Huang, Yi-Chun Taipei, TW 32 675
Wang, Yu-Shan Taipei, TW 13 41

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Sep 29, 2025
7.5 Year Payment $3600.00 $1800.00 $900.00 Sep 29, 2029
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 29, 2033
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00